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Opportunity and Significance
Coronary heart disease (CHD) is the most common type of heart
disease.1 One current method used to address CHD is Coronary
Artery Bypass Grafting (CABG). CABG is an effective method,
with a 95-98% success rate.1 However, the procedure could be
optimized by eliminating the need for the invasive dissection of a
healthy vein or artery and the risk of rejection in the cases with a
donor vessel.
Technical Approach,  Accomplishments and  
Results
Preliminary tensile data taken during the optimization of seeding
parameters are shown in Figure 2. Histology of one ring is shown
in Figure 3. ASC’s were successfully differentiated into fibroblasts
as shown in the PCR data of Figure 4.
Next Steps for Development and Test
Once the ASC-fibroblast ring constructs are optimized
individually for strength and cellularity, the rings will be
stacked to form a vascular graft. Tensile testing and
histology on the vascular graft will then be done to
characterize its strength and the integration of individual
rings. Burst pressure will be analyzed to characterize the
circumferential strength of the vascular graft, which is
essential in validating its functionality.
Technical Objectives
This project aims to differentiate Adipose-derived stem cells into
fibroblasts through the addition of platelet-derived growth factor
(PDGF) into the culture media. Differentiation protocol will be
optimized, then successful differentiation will be verified through
PCR analysis. The ASC-fibroblasts will then be seeded into a ring
construct as outlined by the protocol by Dr. Lam et al.2 The ring
constructs will be tensile tested and analyzed through histology to
characterize their strength and cellularity.
Related Work and State of Practice
Dr. Lam’s Cardiovascular Regenerative Mechanics Lab has
outlined a method with which scalable ring constructs can be
formed with polydimethylsiloxane (PDMS) center posts and
seeded fibrin hydrogel.2 This work has been expanded to include
3D-printed inserts as the center posts and has been published in
JOVE. Their published work has been done using smooth muscle
cells and fibroblasts. This project uses the scalable ring construct
method, shown in Figure 1, with ASC-fibroblasts.
Commercialization Plan & Partners
This project was done under the guidance of Dr. Lam
and in collaboration with Alexander Pietroski and Tannia
Rodriguez. We are continuing the work for this project at
least through the upcoming Summer and Fall 2018.
The main target consumer for a successful ASC-
fibroblast vascular graft would be a cardiovascular
surgeon. Dr. Lam’s lab communicates frequently with Dr.
Kabbani, a cardiovascular surgeon. Moving forward to
commercialization, other cardiovascular surgeons would
be approached to confirm the handling ability of the
vascular grafts. Clinical trials would also have to be
conducted in order to validate the long-term durability of
the ring constructs prior to commercialization.
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ASC-FIB	PRELIMINARY	TENSILE	DATA	(1MM	THICKNESS)
Sample	1 Sample	2 Sample	3 Sample	4
Sample	(n=4)E UTS FS
1 7.919 109.499 18.144
2 8.540 58.569 12.732
3 8.993 91.673 14.961
4 11.336 124.141 15.597
Average 9.197 95.970 15.358
SDV 1.493 28.248 2.226
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Figure	2:	Tensile	Test	Results
Figure	4:	PCR	Results
Figure	3:	H&E	stain	on	one	ring	10x	
magnification
Figure	1:	Scalable	Ring	Construct	Method
